Supporting the lack of predictive biomarker potential in melanoma [3], TP53 mutation, was not significantly associated with melanoma-specific survival, metastasis-free survival, Breslow thickness, or Clarke’s microanatomical level (Additional file 1: Fig. S6B-E). This evidence concerns the gene TP53 and melanoma.